Sandwalk BioVentures will proudly sponsor and join tens of microbiome companies at the Pharmabiotics Event, taking place on 20-21 of April in Lyon, France.
On April 21st, Sandwalk’s Managing Director, Dr. Luis Gosálbez, will be presenting “The GMO-microbiome drug development landscape” where he will give an overview of the role of the genetic modification of microorganisms to augment or expand their native metabolic capabilities, and use them as long-term drug delivery systems, as vaccines or as gene therapy agents in a wide range of diseases, from infections to metabolic disorders to cancer.
For more information or to meet us at the conference, contact us.